This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, A.
Right arrow Articles by Nagai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, A.
Right arrow Articles by Nagai, Y.

 Previous Article  |  Next Article 

Journal of Virology, April 2007, p. 3264-3271, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02590-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Importance of the Anti-Interferon Capacity of Sendai Virus C Protein for Pathogenicity in Mice{triangledown}

Atsushi Kato,1* Katsuhiro Kiyotani,2 Toru Kubota,1 Tetsuya Yoshida,2 Masato Tashiro,1 and Yoshiyuki Nagai3

Department of Virology 3, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011,1 Department of Virology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551,2 Center of Research Network for Infectious Diseases, RIKEN, Tokyo 100-0006, Japan3

Received 22 November 2006/ Accepted 2 January 2007

The Sendai virus (SeV) C protein blocks signal transduction of interferon (IFN), thereby counteracting the antiviral actions of IFN. Using HeLa cell lines expressing truncated or mutated SeV C proteins, we found that the C-terminal half has anti-IFN capacity, and that K151A, E153A, and R154A substitutions in the C protein eliminated this capacity. Here, we further created the mutant virus SeV Cm*, in which K151A, E153K, and R157L substitutions in the C protein were introduced without changing the amino acid sequence of overlapped P, V, and W proteins. SeV Cm* was found to lack anti-IFN capacity, as expected. While the growth rate and final yield of SeV Cm* were inferior to those of the wild-type SeV in IFN-responsive, STAT1-positive 2fTGH cells, SeV Cm* grew equivalently to the wild-type SeV in IFN-nonresponsive, STAT1-deficient U3A cells. SeV Cm* was thus shown to maintain multiplication capacity, except that it lacked anti-IFN capacity. Intranasally inoculated SeV Cm* could propagate in the lungs of STAT1–/– mice but was cleared from those of STAT1+/+ mice without propagation. It was found that the anti-IFN capacity of the SeV C protein was indispensable for pathogenicity in mice. Conversely, the results show that the innate immunity contributed to elimination of SeV in early stages of infection in the absence of anti-IFN capacity.

* Corresponding author. Mailing address: Department of Virology 3, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashi-Murayama, Tokyo 208-0011, Japan. Phone: 81 42 561 0771, ext. 530. Fax: 81 42 567 5631. E-mail: akato{at}nih.go.jp.

{triangledown} Published ahead of print on 10 January 2007.

Journal of Virology, April 2007, p. 3264-3271, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02590-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chambers, R., Takimoto, T. (2009). Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. J. Gen. Virol. 90: 1906-1915 [Abstract] [Full Text]  
  • Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., Yanagi, Y. (2008). Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins. J. Virol. 82: 8296-8306 [Abstract] [Full Text]  
  • Davis, A. M., Hagan, K. A., Matthews, L. A., Bajwa, G., Gill, M. A., Gale, M. Jr., Farrar, J. D. (2008). Blockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network. J. Immunol. 180: 6923-6932 [Abstract] [Full Text]  
  • Thakur, C. S., Jha, B. K., Dong, B., Das Gupta, J., Silverman, K. M., Mao, H., Sawai, H., Nakamura, A. O., Banerjee, A. K., Gudkov, A., Silverman, R. H. (2007). Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc. Natl. Acad. Sci. USA 104: 9585-9590 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»